Latest news

• EU and UK pharma leaders appeal directly to Brexit negotiators

  Eight associations from the UK and Europe have written an open letter to the negotiators to plead for an early partnership agreement on medicines, saying that drugs could be "held either ... An implementation period that adequately reflects the time

• UK pharma strikes optimistic note as Brexit process begins

  All eyes are now on the preliminary response to the letter triggering Brexit - which European Council president Donald Tusk has said will be ready on Friday – and which expressed Prime Minister ... Industry eyes no doubt latched onto May emphasising

• Biotech leaders slam Trump over immigration order

  Biotech leaders slam Trump over immigration order. Former Teva CEO Jeremy Levin heads open letter expressing “ deep concern and opposition”. ... In an open letter published in Nature Biotech yesterday, the biotech leaders express "deep concern and

• UK biotech beats fundraising records in 2015, says BIA

  Last month, more than 90 top executives in the UK's biopharma industry added their names to an open letter warning of "complexity and uncertainty" if the UK votes to leave

• ABPI says UK role as clinical trial hub threatened by Brexit

  Earlier this month, the trade organisation lent its signature to an open letter from more than 90 top executives in the UK biopharma industry which warned of "increased complexity and uncertainty"